Aspergillosis: Nebulized liposomal amphotericin-B for maintenance therapy?

被引：0
|
作者：
Simon, Annika
机构：
来源：
PNEUMOLOGIE | 2023年 / 77卷 / 01期
关键词：
D O I：
10.1055/a-1947-3950
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Die Allergische bronchopulmonale Aspergillose (ABPA) ist eine seltene, immunbedingte Lungenerkrankung und au ss ert sich klinisch mit schlecht therapierbarem Asthma und rezidivierenden Lungeninfiltraten. Godet et al. wollten wissen, ob eine Erhaltungstherapie mit vernebeltem liposomalem Amphotericin-B die Rezidivrate akuter Exazerbationen reduzieren kann, und prasentieren nun die Ergebnisse ihrer randomisierten Studie.
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [1] Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial
    Godet, Cendrine
    Couturaud, Francis
    Marchand-Adam, Sylvain
    Pison, Christophe
    Gagnadoux, Frederic
    Blanchard, Elodie
    Taille, Camille
    Philippe, Bruno
    Hirschi, Sandrine
    Andrejak, Claire
    Bourdin, Arnaud
    Chenivesse, Cecile
    Dominique, Stephane
    Bassinet, Laurence
    Murris-Espin, Marlene
    Riviere, Frederic
    Garcia, Gilles
    Caillaud, Denis
    Blanc, Francois-Xavier
    Goupil, Francois
    Bergeron, Anne
    Gondouin, Anne
    Frat, Jean-Pierre
    Flament, Thomas
    Camara, Boubou
    Priou, Pascaline
    Brun, Anne-Laure
    Laurent, Francois
    Ragot, Stephanie
    Cadranel, Jacques
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (06)
  • [2] LIPOSOMAL AMPHOTERICIN-B IN THE CONTROL OF EXPERIMENTAL ASPERGILLOSIS IN MICE .1. RELATIVE THERAPEUTIC EFFICACY OF FREE AND LIPOSOMAL AMPHOTERICIN-B
    AHMAD, I
    SARKAR, AK
    BACHHAWAT, BK
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 1989, 26 (06): : 351 - 356
  • [3] Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis
    Gavaldà, J
    Martín, MT
    López, P
    Gomis, X
    Ramírez, JL
    Rodríguez, D
    Len, O
    Puigfel, Y
    Ruíz, I
    Pahissa, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) : 3028 - 3030
  • [4] NEBULIZED AMPHOTERICIN-B AS PROPHYLAXIS AGAINST INVASIVE ASPERGILLOSIS IN GRANULOCYTOPENIC PATIENTS
    CONNEALLY, E
    CAFFERKEY, MT
    DALY, PA
    KEANE, CT
    MCCANN, SR
    BONE MARROW TRANSPLANTATION, 1990, 5 (06) : 403 - 406
  • [5] LIPOSOMAL AMPHOTERICIN-B
    VINCENT, M
    WEBSTER, MH
    PETHER, JVS
    LANCET, 1992, 339 (8789): : 374 - 375
  • [6] LIPOSOMAL AMPHOTERICIN-B THERAPY OF MURINE HISTOPLASMOSIS
    GRAYBILL, JR
    BOCANEGRA, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) : 1885 - 1887
  • [7] LIPOSOMAL AMPHOTERICIN-B THERAPY IN DISSEMINATED HISTOPLASMOSIS
    HARTEN, P
    BARON, Y
    EULER, HH
    ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (14) : 1556 - 1556
  • [8] LIPOSOMAL AMPHOTERICIN-B TREATMENT OF ASPERGILLOSIS IN A RENAL-TRANSPLANT PATIENT
    ELLIS, ME
    BOHLEGA, S
    HALIM, MA
    QUNIBI, W
    THARPE, W
    SAUDI MEDICAL JOURNAL, 1993, 14 (05) : 469 - 470
  • [9] USE OF NEBULIZED LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT OF ASPERGILLUS-FUMIGATUS EMPYEMA
    PURCELL, IF
    CORRIS, PA
    THORAX, 1995, 50 (12) : 1321 - 1323
  • [10] Amphotericin-B/amphotericin-B liposomal/immunosuppressantsVarious toxicities: case report
    Reactions Weekly, 2019, 1749 (1) : 42 - 42
12345